Physiological evidence for interaction between the HIV-1 co-receptor CXCR4 and the cannabinoid system in the brain
Physiological evidence for interaction between the HIV-1 co-receptor CXCR4 and the cannabinoid system in the brain
复制标题
DOI:
10.1111/j.1476-5381.2009.00285.x
复制
发表时间:
2009-08-01
影响因子:
7.3
通讯作者:
Adler, Martin W.
中科院分区:
文献类型:
--
作者:
Benamar, Khalid;Yondorf, Menachem;Adler, Martin W.
Background and purpose:The chemokine, stromal cell-derived growth factor-1 alpha (SDF-1 alpha/CXCL12), a member of the CXC chemokine family, and the ligand for CXCR4, the co-receptor involved in the entry of human immunodeficiency virus-1 (HIV-1), was tested for its possible interaction with a physiological response to a cannabinoid.Experimental approach:The cannabinoid agonist, an aminoalkylindole, (+)-WIN 55,212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one], was infused directly into the preoptic anterior hypothalamus (POAH), the primary brain area involved in thermoregulation.Key results:WIN 55,212-2 (5-15 mu g) evoked a dose-related hypothermia, which was attenuated by SDF-1 alpha/CXCL12 microinjected directly into the POAH. The inhibitory effect of SDF-1 alpha/CXCL12 on WIN 55,212-2-induced hypothermia was reversed by 1,1'-[1,4-phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane] octohydrobromide dihydrate, an antagonist of SDF-1 alpha/CXCL12, acting at its receptor, CXCR4.Conclusion and implications:This study provides the first in vivo evidence for a thermoregulatory interaction between the HIV-1 co-receptor and the cannabinoid system in the brain.